Clinical Trials Logo

Filter by:
NCT ID: NCT04576156 Recruiting - Myelofibrosis Clinical Trials

A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

Start date: April 12, 2021
Phase: Phase 3
Study type: Interventional

The purpose of the study is to evaluate the overall survival of participants treated with imetelstat compared to best available therapy with intermediate-2 or high-risk Myelofibrosis (MF) who are relapsed/refractory to Janus Kinase (JAK)-Inhibitor treatment.

NCT ID: NCT04581759 Recruiting - Clinical trials for Acute Ischemic Stroke

Endovascular Treatment and RIPC in Acute Ischemic Stroke

EnTRIPS
Start date: April 12, 2021
Phase: N/A
Study type: Interventional

Endovascular treatment(ET)is an effective therapy for acute ischemic stroke(AIS) with great vessel obstruction. However, acute complications such as high postoperative perfusion injury, hemorrhagic transformation and restenosis resulted in functional independence in only about 50% of patients 90 days after interventional surgery. Therefore, it is very important to protect the neurologic function after emergency endovascular treatment. The investigators' previous studies have shown that combined with intravenous thrombolytic therapy and remote postconditioning(RIPC)can significantly improve the neurological impairment and short-term and long-term prognosis in patients with acute stroke. In this multicenter, randomized controlled trial, the investigators assumed patients with acute ischemic stroke who had successfully revascularization after ET might benefit from RIPC as well. Patients in the RIPC group had five cycles of 5-min cuff inflation followed by 3-min deflation to the bilateral upper arm after ET. The primary endpoint measure was the proportion of patients with a favorable recovery of nerve function deficient assessed by Modified Rankin Scale (mRS≤2) 90 days after surgery. Secondary endpoints included the following: (1) Symptom endpoints: Neurological intelligence and function scores, postoperative hemorrhagic transformation rate, etc. (2) Blood index test: postoperative inflammatory factors, neuron-specific enolase (NSE) and other indicators. (3) Imaging endpoints: MRI-FLAIR , TCD, etc.

NCT ID: NCT04667585 Recruiting - Oropharynx Cancer Clinical Trials

Radiotherapy Dose De-escalation in HPV-Associated Cancers of the Oropharynx

Start date: April 12, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to use intra-treatment 18FDG-PET/CT during definitive radiation therapy for human papillomavirus (HPV)-related oropharyngeal cancer (OPC) as an imaging biomarker to identify and select patients with a favorable response for chemoradiation dose de-escalation. This study will prospectively evaluate the clinical outcomes for patients undergoing dose de-escalation.

NCT ID: NCT04680377 Recruiting - NSCLC, Stage III Clinical Trials

Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients

Microdurva
Start date: April 12, 2021
Phase:
Study type: Observational

This phase IV study is hoping to determine if examining the microbiome in non-small cell lung cancer participants who will receive durvalumab can predict treatment toxicity.

NCT ID: NCT04702139 Recruiting - Clinical trials for Shoulder Osteoarthritis

Use of the "Game-Ready" Splint for Better Recovery in Primary Total Shoulder Arthroplasty

game-ready
Start date: April 12, 2021
Phase: N/A
Study type: Interventional

The aim of the study is to compare the level of postoperative pain after fitting the Game Ready splint, at 48 hours versus that observed with fitting a standard splint

NCT ID: NCT04705480 Recruiting - Pain Clinical Trials

Pregabalin vs. Gabapentin on Reducing Opioid Usage

Start date: April 12, 2021
Phase: Phase 4
Study type: Interventional

This is a single-center, randomized, open-label, Phase 4 clinical trial investigating the efficacy of multiple-dose administrations of Pregabalin or Gabapentin in combination with traditional opioid pain medications to decrease the amount of opioid pain medication usage in single-system orthopedic trauma patients.

NCT ID: NCT04722796 Recruiting - Aortic Stenosis Clinical Trials

HANGZHOU Solution in Bicuspid AS Undergoing TAVR

Start date: April 12, 2021
Phase: N/A
Study type: Interventional

To compare supra-annular sizing and THV implantation technique (Hangzhou solution) versus annular sizing and THV implantation technique (control group) in bicuspid aortic stenosis (AS) patients undergoing transcatheter aortic valve replacement (TAVR) with self-expanding valves (SEVs): a randomized superiority trial

NCT ID: NCT04729283 Recruiting - Sigmoid Cancer Clinical Trials

Comparison of Quality of Life and Functionnal Resultats After Sigmodectomy Between Diverticulitis and Cancer

SIG-QOL
Start date: April 12, 2021
Phase:
Study type: Observational

The aim of this present study is to compare functional results and quality of life after sigmoidectomy for diverticulitis and sigmoid cancer.

NCT ID: NCT04731155 Recruiting - Clinical trials for Early PCSK9 Inhibitor on Ventricular Remodling

Impact of Early PCSK9 Inhibitor on Heart After Acute Myocardium Infarction

PERFECT-AMI
Start date: April 12, 2021
Phase: Phase 4
Study type: Interventional

This is a prospect, multi-center, random study to investigate whether early offering PCSK9 inhibitor to acute myocardium infarction(AMI) can alleviate ventricular remodeling after primary percutaneous intervention(PPCI). Totally,twenty acute myocardium infarction subjects will be enrolled in this study after consent information. After randomization, the control group will receive standard therapy for AMI including PPCI. The experiment group will receive first PCSK9 inhibitor before PPCI, then twice a month until 3 months later. Six month after AMI, Myocardial salvage index will be used to evaluate ventricular remodeling. TnI peaking time and LDL control rates also will be recorded and compared.

NCT ID: NCT04758663 Recruiting - Sleep Clinical Trials

The Role of Naps and Overnight Sleep on Cognitive Learning in Preschoolers

Start date: April 12, 2021
Phase: N/A
Study type: Interventional

The goal of this research is to understand the role of sleep on memory function in early childhood. Specifically, we seek to examine how promoted naps vs. promoted waking in habitual and non-habitual napping children may impact overnight sleep physiology and subsequent memory consolidation.